Clinical Trials in Maryland

Showing 3121-3140 of 23,284 trials

Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

NCT07216378

The sebetralstat Early Access Program (EAP) provides early access to the investigational medicinal product (IMP) sebetralstat to eligible and approved Hereditary Angioedema (HAE) pediatric (ages 2-11) post-trial and naïve patients for the on-demand treatment of angioedema attacks where the treating Physician determines they might benefit from this treatment.

Hereditary Angioedema

KalVista Pharmaceuticals, Ltd.

Evansville, Indiana, United States • Wheaton, Maryland, United States • St Louis, Missouri, United States

COMPLETEDPhase 314 miles

Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)

NCT04385303

This phase 3 study is a multicenter, randomized, double-blind, placebo-controlled study of lorecivivint injected intraarticularly (IA) into the target knee (most painful) joint of moderately to severely symptomatic osteoarthritis (OA) subjects at a single dose of 0.07 mg lorecivivint per 2 mL injection. This study will utilize patient reported outcomes (PROs) to evaluate the safety and efficacy of lorecivivint.

Knee Osteoarthritis

Biosplice Therapeutics, Inc.496 participantsStarted May 2020

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +73 more locations

Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)

Find Trials by Condition in Maryland

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Circuitry Assessment and Reinforcement Training Effects on Recovery

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

Randomized Study of the pdSTIM™ System in Failure to Wean Mechanically Ventilated Patients

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

International CRDS Registry

A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive

A Study of Avoralstat In Participants With Diabetic Macular Edema

A Study of EBC-129 in Advanced Solid Tumours